Form 483

CSB Nutrition Corporation Form 483, 2020-03-20

FDA issued a Form 483 to CSB Nutrition Corporation on 2020-03-20 with 5 public-safe observations.

483· Form 483 issuedFoods & Cosmetics5 observations

CSB Nutrition Corporation · Spanish Fork, United States · Issued March 20, 2020

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Mar 2020
21 CFR 111.105(i)

QC - required operations master manufacturing/batch records

Cited by Matthew A Johnson, Richard T Jensen, Brandon K Lawson

20 Mar 2020
21 CFR 111.205(a)

Master manufacturing record - each batch

Cited by Matthew A Johnson, Richard T Jensen, Brandon K Lawson

20 Mar 2020
21 CFR 111.205(c)

Master manufacturing record: electronic

Cited by Matthew A Johnson, Richard T Jensen, Brandon K Lawson

20 Mar 2020
21 CFR 117.130(a)(1)

Hazard Analysis - Identification of Hazard

Cited by Matthew A Johnson, Richard T Jensen, Brandon K Lawson

20 Mar 2020
21 CFR 117.145(a)

Process Controls Monitoring Procedures: Establish Implement

Cited by Matthew A Johnson, Richard T Jensen, Brandon K Lawson

Inspected site

CNCSB Nutrition CorporationSpanish Fork, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.105(i)Cited across public-safe Form 483 observations1x
21 CFR 111.205(a)Cited across public-safe Form 483 observations1x
21 CFR 111.205(c)Cited across public-safe Form 483 observations1x
21 CFR 117.130(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 117.145(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere